This inventor holds 6 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Xenoport, Inc.. Active years: 2009-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2016
Title: Archana Gangakhedkar: Innovator in Pharmaceutical Sciences
Introduction
Archana Gangakhedkar is a prominent inventor based in San Jose, California. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of prodrugs for various diseases. With a total of six patents to her name, her work has the potential to impact the treatment of several chronic conditions.
Latest Patents
Her latest patents focus on methods of using prodrugs of methyl hydrogen fumarate. These patents disclose pharmaceutical compositions that comprise prodrugs of methyl hydrogen fumarate and methods for using these compositions to treat diseases such as psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, and arthritis. The innovative approaches outlined in her patents aim to enhance the efficacy and safety of treatments for these conditions.
Career Highlights
Archana is currently employed at Xenoport, Inc., where she continues to advance her research in pharmaceutical development. Her work at Xenoport has positioned her as a key player in the industry, contributing to the company's mission of improving patient outcomes through innovative therapies.
Collaborations
Throughout her career, Archana has collaborated with notable colleagues, including Xuedong Dai and Noa Zerangue. These collaborations have fostered a dynamic research environment, allowing for the exchange of ideas and expertise in the field.
Conclusion
Archana Gangakhedkar's contributions to pharmaceutical sciences through her innovative patents and collaborative efforts highlight her role as a leading inventor in the industry. Her work promises to bring new hope to patients suffering from chronic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile